Sanofi Makes Case For Frontline Use Of Myeloma Drug Sarclisa

Promising Data In Newly Diagnosed Transplant-Eligible Patients

 
• By Kevin Grogan
  
Big dart
Four may be better than three when targeting multiple myeloma • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapy Areas